4//SEC Filing
Ostertag Eric 4
Accession 0001209191-23-006828
CIK 0001661460other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:19 PM ET
Size
7.5 KB
Accession
0001209191-23-006828
Insider Transaction Report
Form 4
Ostertag Eric
DirectorChief Executive Officer10% Owner
Transactions
- Tax Payment
Common Stock
2023-02-01$7.00/sh−11,776$82,432→ 827,320 total
Holdings
- 3,659,503(indirect: See footnote)
Common Stock
- 961,445(indirect: See footnote)
Common Stock
- 580,292(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2022.
- [F2]The shares are held in the name of the Eric Ostertag Living Trust dated March 30, 2016, of which the reporting person is the sole trustee.
- [F3]The shares are held in the name of Twin Prime Investments, an entity wholly owned by the reporting person.
- [F4]The shares are held in the name of the Ostertag Family Trust dated March 30, 2016, of which the reporting person is a trustee.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001765987
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:19 PM ET
- Size
- 7.5 KB